5-144473952-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020768.4(KCTD16):āc.1125A>Cā(p.Glu375Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020768.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCTD16 | NM_020768.4 | c.1125A>C | p.Glu375Asp | missense_variant | 4/4 | ENST00000512467.6 | NP_065819.1 | |
KCTD16 | NM_001370486.1 | c.1125A>C | p.Glu375Asp | missense_variant | 3/3 | NP_001357415.1 | ||
KCTD16 | NM_001370487.1 | c.1125A>C | p.Glu375Asp | missense_variant | 3/3 | NP_001357416.1 | ||
KCTD16 | XM_005268493.3 | c.1125A>C | p.Glu375Asp | missense_variant | 3/3 | XP_005268550.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250320Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135504
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461826Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727212
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2024 | The c.1125A>C (p.E375D) alteration is located in exon 4 (coding exon 2) of the KCTD16 gene. This alteration results from a A to C substitution at nucleotide position 1125, causing the glutamic acid (E) at amino acid position 375 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at